![Michael Huang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Huang
Directeur/Membre du Conseil chez
ANNJI PHARMACEUTICAL CO., LTD.
Profil
Michael Huang currently serves as manager at CX Venture Capital Group with focus on life sciences investment in the North America regions.
Mr. Huang is currently an observer on the Board of Directors for Nellix, Inc., a star-up medical device company focusing on the development of the AAA endografts.
Mr. Huang brings several years of experiences in financial/strategic planning and marketing.
Prior to joining CX, Mr. Huang took a position as Lead Chemical Engineer at Nan Pao Resins Group where Mr. Huang was responsible for the implementation of ERP programs with several major clients and for the promotion of new water-based adhesive products.
Prior to Nan Pao, Mr. Huang was a financial analyst at Continental Airlines¡¦ technical operation group.
Mr. Huang received an MS degree in Chemistry from University of Texas at Arlington and an MBA from Rice University.
Postes actifs de Michael Huang
| Sociétés | Poste | Début |
|---|---|---|
| ANNJI PHARMACEUTICAL CO., LTD. | Directeur/Membre du Conseil | 03/05/2019 |
Cheng Xin Venture Capital Group
 Cheng Xin Venture Capital Group Investment ManagersFinance CXVCG's fund investment objective seeks superior returns. Their fund investment strategy targets firms operating primarily in biotechnology/life sciences (pharmaceuticals, medical devices, bioinformatics, healthcare services and agricultural biotechnology) and high technology (energy, electronics, optoelectronics, communications, information technology and software). They provide financing for early and expansion stage capital requirements. Investment criteria they look for include firms with a strong proprietary position, breakthrough technology responding to a large potential market, and managed by experienced entrepreneurs. They also encourage synergies of technologies or products between their portfolio firms. CXVCG looks for firms in the Asia Pacific region as well as in North America. They are active, involved investment partners. In addition to providing capital, they support their portfolio firms with the development of corporate strategy, building strategic alliances and recruitment of top management. | Private Equity Investor | - |
Taiwania Capital Management Corp.
 Taiwania Capital Management Corp. Investment ManagersFinance Acts as an alternative investment manager | Private Equity Investor | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Cheng Xin Venture Capital Group
Cheng Xin Venture Capital Group Investment ManagersFinance CXVCG's fund investment objective seeks superior returns. Their fund investment strategy targets firms operating primarily in biotechnology/life sciences (pharmaceuticals, medical devices, bioinformatics, healthcare services and agricultural biotechnology) and high technology (energy, electronics, optoelectronics, communications, information technology and software). They provide financing for early and expansion stage capital requirements. Investment criteria they look for include firms with a strong proprietary position, breakthrough technology responding to a large potential market, and managed by experienced entrepreneurs. They also encourage synergies of technologies or products between their portfolio firms. CXVCG looks for firms in the Asia Pacific region as well as in North America. They are active, involved investment partners. In addition to providing capital, they support their portfolio firms with the development of corporate strategy, building strategic alliances and recruitment of top management. | Finance |
Annji Pharmaceutical Co., Ltd.
 Annji Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Engages in research and development of drugs | Health Technology |
Taiwania Capital Management Corp.
Taiwania Capital Management Corp. Investment ManagersFinance Acts as an alternative investment manager | Finance |
Choisissez Zonebourse 
